A detailed history of American Century Companies Inc transactions in Bio N Tech Se stock. As of the latest transaction made, American Century Companies Inc holds 75,554 shares of BNTX stock, worth $8.43 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
75,554
Previous 86,924 13.08%
Holding current value
$8.43 Million
Previous $6.99 Million 28.46%
% of portfolio
0.01%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$78.36 - $124.66 $890,953 - $1.42 Million
-11,370 Reduced 13.08%
75,554 $8.97 Million
Q4 2023

Feb 13, 2024

BUY
$90.91 - $112.75 $7.9 Million - $9.8 Million
86,924 New
86,924 $9.17 Million
Q3 2023

Nov 13, 2023

BUY
$98.5 - $125.08 $41,468 - $52,658
421 Added 0.48%
87,356 $9.49 Million
Q2 2023

Aug 14, 2023

SELL
$102.58 - $129.66 $3.55 Million - $4.49 Million
-34,614 Reduced 28.48%
86,935 $9.38 Million
Q1 2023

May 11, 2023

BUY
$122.57 - $153.67 $5.62 Million - $7.05 Million
45,856 Added 60.58%
121,549 $15.1 Million
Q4 2022

Feb 13, 2023

BUY
$118.43 - $186.05 $4.31 Million - $6.77 Million
36,365 Added 92.47%
75,693 $11.4 Million
Q3 2022

Nov 14, 2022

BUY
$127.65 - $183.11 $681,395 - $977,441
5,338 Added 15.7%
39,328 $5.31 Million
Q1 2022

May 11, 2022

BUY
$126.25 - $231.85 $583,780 - $1.07 Million
4,624 Added 15.75%
33,990 $5.8 Million
Q4 2021

Feb 07, 2022

BUY
$216.64 - $362.52 $808,717 - $1.35 Million
3,733 Added 14.56%
29,366 $7.57 Million
Q3 2021

Nov 10, 2021

BUY
$205.93 - $447.23 $5.28 Million - $11.5 Million
25,633 New
25,633 $7 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.1B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.